Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function.
about
Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes?Long-term successful weight loss improves vascular endothelial function in severely obese individuals.Long-term effects of early overnutrition in the heart of male adult rats: role of the renin-angiotensin systemEtiology and treatment of erectile failure in diabetes mellitus.Mechanisms for early microvascular injury in obesity and type II diabetes.Gender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C beta and superoxide but not of Rho kinase.NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivoTransfer of nitric oxide by blood from upstream to downstream resistance vessels causes microvascular dilation.Microvascular perfusion heterogeneity contributes to peripheral vascular disease in metabolic syndrome.Nitric oxide and the cardiovascular system.Insulin resistance impairs endothelial function but not adrenergic reactivity or vascular structure in fructose-fed rats.Is the real in vivo nitric oxide concentration pico or nano molar? Influence of electrode size on unstirred layers and NO consumption.Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4).Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome.Venular endothelium-derived NO can affect paired arteriole: a computational model.Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats.Impaired skeletal muscle perfusion in obese Zucker rats.Contribution of nNOS- and eNOS-derived NO to microvascular smooth muscle NO exposure.Comparison of retinal vascular geometry in obese and non-obese children.
P2860
Q30352122-62ACAF71-55DE-4C43-B942-70812E04FAA8Q33803736-7BFD2D9D-2AA2-49CF-862D-CF267406DDA5Q34766179-51DECAD1-F264-461F-A714-AFCC606DA3B2Q35087516-A24ED84D-114C-4A4B-A666-B30596B3A77AQ35670662-B0FC6E76-0F16-4757-B3C3-23F322E9F97EQ36248761-1AF2FD60-EEDC-4726-91EE-51192C51C1DDQ36893418-4AB073BC-116B-4085-8708-347C9F381D1BQ37406355-BF691EF6-CC42-4FDD-A47D-ED836DB1CF13Q38266686-5D8561FB-E3BC-4A67-90CA-2ED4373EFC8AQ38423876-236175DA-1D1F-4EFF-BFFE-BE05BB52BC3BQ42036012-BA9BC16E-792F-4AE9-9E36-9C2023B6AD4EQ42112627-E3A92716-EC32-42E6-8951-4480FAA21EE5Q44814386-D743DC37-FD03-418F-AB0A-393AE7727406Q44909589-443C64AD-C783-4434-83E4-6BE23A356CE0Q46697046-6198F397-0870-4446-B085-6A6B3A7CFA84Q46801064-542EC3D2-BAAF-4C45-94C6-A153010B740BQ47767120-4C16F345-5769-4ADD-8050-4F6D73391FDCQ47915711-94855935-8204-4CC9-AFCC-96E4BC405EAEQ48123894-9ACF8059-6A78-4DD6-9F58-714103AFE4CD
P2860
Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Obesity lowers hyperglycemic t ...... thelial nitric oxide function.
@en
Obesity lowers hyperglycemic t ...... thelial nitric oxide function.
@nl
type
label
Obesity lowers hyperglycemic t ...... thelial nitric oxide function.
@en
Obesity lowers hyperglycemic t ...... thelial nitric oxide function.
@nl
prefLabel
Obesity lowers hyperglycemic t ...... thelial nitric oxide function.
@en
Obesity lowers hyperglycemic t ...... thelial nitric oxide function.
@nl
P2860
P921
P1476
Obesity lowers hyperglycemic t ...... thelial nitric oxide function.
@en
P2093
Geoffrey P Nase
H G Bohlen
P2860
P304
P356
10.1152/AJPHEART.00019.2002
P577
2002-07-01T00:00:00Z